Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Elevated neutrophil count is associated with higher risk of major adverse cardiac events including myocardial infarction and early development of heart failure. Neutrophils contribute to cardiac damage through a number of mechanisms, including attraction of other immune cells and release of inflammatory mediators. Recently, a number of independent studies have reported a causal role for neutrophil-derived alarmins (i.e. S100A8/A9) in inducing inflammation and cardiac injury following myocardial infarction (MI). Furthermore, a positive correlation between serum S100A8/A9 levels and major adverse cardiac events (MACE) in MI patients was also observed implying that targeting neutrophils or their inflammatory cargo could be beneficial in reducing heart failure. However, contradictory to this idea, neutrophils and neutrophil-derived S100A8/A9 also seem to play a vital role in the resolution of inflammation. Thus, a better understanding of how neutrophils balance these seemingly contrasting functions would allow us to develop effective therapies that preserve the inflammation-resolving function while restricting the damage caused by inflammation. In this review, we specifically discuss the mechanisms behind neutrophil-derived S100A8/A9 in promoting inflammation and resolution in the context of MI. We also provide a perspective on how neutrophils could be potentially targeted to ameliorate cardiac inflammation and the ensuing damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202
Efficacy and safety of low-dose colchicine after myocardial infarction
Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1912388 · Cited by 3,159 · cited 1×
“Another trial, The Colchicine Cardiovascular Outcomes Trial (COLCOT) that investigated the efficacy of colchicine to reduce the risk of cardiovascular events after MI found similar data (11).”
BackgroundA small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418 · cited 4×
“S100A8/A9 binding to TLR4 and RAGE activates inflammatory pathways that lead to secretion of multiple cytokines that sustain or exacerbate inflammation (69, 83, 84).”
BackgroundInfluentialManz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855
Chronic variable stress activates hematopoietic stem cells
Heidt, T., Sager, H. B., Courties, G., Dutta, P., Iwamoto, Y., Zaltsman, A., von zur Muhlen, C., Bode, C., Fricchione, G. L., Denninger, J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3589 · Cited by 803 · cited 1×
“Activation of sympathetic nervous system (SNS) or increase in NE levels post-MI could also induce neutrophilia via disruption of CXCR4-SDF1 axis(50) suggesting that stress could play a role in MI-induced granulopoiesis.”
BackgroundG-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood
Semerad, C. L., Liu, F., Gregory, A. D., Stumpf, K., & Link, D. C. (2002) · Immunity · doi:10.1016/s1074-7613(02)00424-7 · Cited by 450 · cited 5×
“1 and C/EBPα/ε in myeloid precursors in the BM(34, 51).”
BackgroundInfluentialSoro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
Deftereos, S., Giannopoulos, G., Papoutsidakis, N., Panagopoulou, V., Kossyvakis, C., Raisakis, K., Cleman, M. W., & Stefanadis, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.726 · Cited by 161
Cited by
Liu, C., He, Y.-X., Zhang, J.-N., Yang, F., Wang, S.-Y., Hu, J.-L., & Yu, Y. (2023) · Phytomedicine · doi:10.1016/j.phymed.2022.154490 · Cited by 27
Zhu, H.-M., Liu, N., Sun, D.-X., & Luo, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1202298 · Cited by 12
“S100A8 is typically present as a dimer and forms a complex with S100A9 protein, known as calprotectin (51, 52).”
BackgroundCai, X., Hong, L., Liu, Y., Huang, X., Lai, H., & Shao, L. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2137421 · Cited by 6
“S100A8/A9 facilitates inflammation and resolution in myocardial infarction [33].”
Background
Metadata
- Authors
- Sreejit, G., Abdel Latif, A., Murphy, A. J., & Nagareddy, P. R.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 161
- Pages
- 105212
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W3089508181
- Cited by
- 72
- References
- 13
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation. https://app.cochat.ai/papers/10.1016/j.phrs.2020.105212
- The paper
- Sreejit, G., Abdel Latif, A., Murphy, A. J., & Nagareddy, P. R. (2020). Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation. Pharmacological Research. https://doi.org/10.1016/j.phrs.2020.105212
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.